Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth |
---|
hl7.fhir.us.davinci-cdex | R4 | ValueSet/cdex-pwk01-attachment-report-type-code | CDex PWK01 Attachment Report Type Code Value Set | trial-use | 2 | claims | 2024-05 | hl7 |
fhir.cqf.common | R4 | ValueSet/inactive-condition | CQF Inactive Condition | active | | | 2019-07 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1095.85 | Nutrition Diagnosis Grouping | active | | | 2024-05 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1095.70 | Nutrition Education SNOMED CT | active | | | 2020-09 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1095.82 | Food and Nutrition Related History Grouping | active | | | 2022-03 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1248.241 | Degenerative Neurological Disorder | active | | | 2023-09 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1248.239 | Neuromuscular Disorder | active | | | 2023-09 | hl7 |
hl7.fhir.us.registry-protocols | R4 | ValueSet/NewYorkHeartAssociation | New York Heart Association Assessment Scale | active | | cic | 2023-11 | hl7 |
hl7.fhir.us.pacio-adi | R4 | ValueSet/ADINoHealthcareAgentIncludedReasonVS | No Healthcare Agent Included Reason | trial-use | 2 | pe | 2025-07 | hl7 |
fhir.cdc.opioid-cds-r4 | R4 | ValueSet/medicationrequest-category-community | ValueSet - Medication Request Category Community | active | | | 2025-07 | hl7 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-cancer-related-surgical-procedure-vs | Cancer-Related Surgical Procedure Value Set | active | 3 | cic | 2025-02 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7961 | Medication (Leptospirosis) | active | | | 2020-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7751 | Type of Link (TB) | active | | | 2017-12 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7860 | Medication Administered Relative to Treatment (Malaria) | active | | | 2018-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.8034 | Medication Duration Unit (Hansen) | active | | | 2021-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.8033 | Frequency Duration Unit (Hansen) | active | | | 2021-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7955 | Location of Initial Diagnosis (Hansen) | active | | | 2020-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7980 | Patient Case Status (Hansen) | active | | | 2020-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7651 | Previous Case Diagnosed By (Rubella) | active | | | 2017-01 | |
hl7.fhir.us.vdor | R4 | ValueSet/vdor-drug-misuse-vs | VDOR Indicated Prescription Drug Misuse or Illicit Drug Use | informative | | pher | 2025-06 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3288 | Vaccination Contraindication (IIS) | active | | | 2010-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.981 | Diagnosed Pneumonia By (VZ) | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.968 | Case Classification Status | active | | | 2008-01 | |
hl7.fhir.us.carin-bb | R4 | ValueSet/C4BBInstitutionalClaimSubType | C4BB Institutional Claim SubType Value Set | trial-use | | fm | 2025-02 | hl7 |
hl7.fhir.us.carin-bb | R4 | ValueSet/C4BBClaimInpatientInstitutionalDiagnosisType | C4BB Claim Inpatient Institutional Diagnosis Type Value Set | trial-use | | fm | 2025-02 | hl7 |
hl7.fhir.us.carin-bb | R4 | ValueSet/C4BBClaimProcedureType | C4BB Claim Procedure Type Value Set | trial-use | | fm | 2025-02 | hl7 |
hl7.fhir.us.carin-bb | R4 | ValueSet/C4BBClaimOutpatientInstitutionalDiagnosisType | C4BB Claim Outpatient Institutional Diagnosis Type Value Set | trial-use | | fm | 2025-02 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3304 | Parotitis Laterality (Mumps) | active | | | 2010-01 | |
hl7.fhir.us.carin-bb | R4 | ValueSet/C4BBClaimProfessionalAndNonClinicianDiagnosisType | C4BB Claim Professional And Non Clinician Diagnosis Type Value Set | trial-use | | fm | 2025-02 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3039 | Isolate Availability EIP Testing | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7244 | History of Disease as Evidence Of Immunity (IIS) | active | | | 2018-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7245 | Serological Evidence Of Immunity (IIS) | active | | | 2014-01 | |
hl7.fhir.us.carin-bb | R4 | ValueSet/C4BBClaimIdentifierType | C4BB Claim Identifier Type Value Set | trial-use | | fm | 2025-02 | hl7 |
hl7.fhir.us.davinci-pct | R4 | ValueSet/PCTPayerProviderNetworkStatusVS | PCT Payer Provider Network Status | trial-use | | fm | 2025-06 | hl7 |
hl7.fhir.us.davinci-pdex | R4 | ValueSet/PriorAuthServiceTypeCodes | Prior Authorization Service Type Codes (X12) | informative | | fm | 2025-06 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7982 | Vaccine Exposure (Brucellosis) | active | | | 2020-01 | |
hl7.fhir.us.davinci-pct | R4 | ValueSet/PCTPayerBenefitPaymentStatusVS | PCT Payer Benefit Payment Status | trial-use | | fm | 2025-06 | hl7 |
hl7.fhir.us.carin-bb | R4 | ValueSet/C4BBPayerBenefitPaymentStatus | C4BB Payer Benefit Payment Status Value Set | trial-use | | fm | 2025-02 | hl7 |
hl7.fhir.us.davinci-pdex | R4 | ValueSet/PDexPayerBenefitPaymentStatus | PDex Payer Benefit Payment Status | informative | | fm | 2025-06 | hl7 |
signal.core.r4 | R4 | ValueSet/questionnaire-dacods-discharge-status | Questionnaire DACODS Discharge Status | draft | 1 | pa | | hl7 |
signal.core.r4 | R4 | ValueSet/questionnaire-dacods-reason-for-discharge | Questionnaire Dacods Reason For Discharge | draft | | | 2023-09 | hl7 |
signal.core.r4 | R4 | ValueSet/questionnaire-ccars-reason-for-discharge | Questionnaire CCARS Reason For Discharge | draft | 1 | pa | | hl7 |
hl7.fhir.us.carin-bb | R4 | ValueSet/C4BBPayerProviderNetworkStatus | C4BB Payer Provider Network Status Value Set | trial-use | | fm | 2025-02 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7158 | State or Province of Exposure | active | | | 2013-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.8035 | Subject of Medication Received (Hansen) | active | | | 2021-01 | |
hl7.fhir.us.davinci-pct | R4 | ValueSet/PCTAEOBProcessNoteVS | PCT AEOB Process Note Types | trial-use | | fm | 2025-06 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7990 | Specimen Type (Anthrax) | active | | | 2020-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3267 | Non-Sterile Specimen (Pediatric Flu) | active | | | 2009-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3264 | Sterile Specimen (Pediatric Flu) | active | | | 2009-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7383 | Death Reporting Event Reason (NCHS) | active | | | 2014-12 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7969 | Specimen Type (Brucellosis) | active | | | 2020-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7974 | Specimen Type (Leptospirosis) | active | | | 2020-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.964 | Adverse Event Previously Reported | active | | | 2008-01 | |
signal.core.r4 | R4 | ValueSet/location-mode | LocationMode | trial-use | 3 | pa | 2019-10 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.957 | Abnormal Chest X-Ray Finding (TB) | active | | | 2008-01 | |
signal.core.r4 | R4 | ValueSet/account-status | AccountStatus | trial-use | 2 | pa | 2019-10 | hl7 |
hl7.fhir.us.carin-bb | R4 | ValueSet/C4BBPayerClaimPaymentStatusCode | C4BB Payer Claim Payment Status Code Value Set | trial-use | | fm | 2025-02 | hl7 |
signal.core.r4 | R4 | ValueSet/location-status | LocationStatus | trial-use | 3 | pa | 2019-10 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.980 | Diagnosed by (VZ) | active | | | 2017-01 | |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1222.580 | NYHA Heart Failure Functional Classifications | active | | | 2024-09 | hl7 |
hl7.fhir.us.breastcancer | R3 | ValueSet/cimi-context-DeltaFlagVS | BC DeltaFlagVS ValueSet | draft | | | 2018-08 | hl7 |
hl7.fhir.us.directory-query | R4 | ValueSet/IndividualSpecialtyAndDegreeLicenseCertificateVS | Individual Specialties, Degrees, Licenses, and Certificates Value Set | active | | | 2022-12 | hl7 |
hl7.fhir.us.davinci-pdex-plan-net | R4 | ValueSet/IndividualSpecialtyAndDegreeLicenseCertificateVS | Individual Specialties, Degrees, Licenses, and Certificates VS | trial-use | | fm | 2025-02 | hl7 |
hl7.fhir.us.ndh | R4 | ValueSet/IndividualSpecialtyAndDegreeLicenseCertificateVS | Individual Specialties, Degrees, Licenses, and Certificates Value Set | trial-use | | pa | 2025-07 | hl7 |
hl7.fhir.us.directory-query | R4 | ValueSet/IndividualAndGroupSpecialtiesVS | Individual and Group Specialties | active | | | 2022-12 | hl7 |
hl7.fhir.us.davinci-pdex-plan-net | R4 | ValueSet/IndividualAndGroupSpecialtiesVS | Individual and Group Specialties | trial-use | | fm | 2025-02 | hl7 |
hl7.fhir.us.ndh | R4 | ValueSet/IndividualAndGroupSpecialtiesVS | Individual and Group Specialties | trial-use | | pa | 2025-07 | hl7 |
fhir.cdc.opioid-cds-r4 | R4 | ValueSet/non-opioid-urine-drug-screening | Non-opioid drug urine screening | active | | | 2023-05 | hl7 |
fhir.cdc.opioid-cds-r4 | R4 | ValueSet/opioid-urine-drug-screening | Opioid drug urine screening | active | | | 2023-05 | hl7 |
fhir.cdc.opioid-cds-r4 | R4 | ValueSet/xylazine-urine-drug-screening-tests | Xylazine drug urine screening tests | active | | | 2024-05 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1095.2 | Food and Nutrient Delivery SNOMED CT | active | | | 2025-05 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.945 | Industry (SIC) | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.8057 | Infant Anti-HCVTest Result (Hepatitis C Perinatal) | active | | | 2021-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.8045 | Infant HCV Antigen Test Result (Hepatitis C) | active | | | 2021-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.8044 | Infant Nucleic Acid Test Result (Hepatitis C) | active | | | 2021-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3123 | Birth Outcome (VPD) | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3122 | Birth Location (VPD) | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.6070 | Infections During Pregnancy - Live Birth (NCHS) | active | | | 2017-01 | |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1096.227 | Findings Related to Medication Management, Infectious Disease Symptoms | active | | | 2021-03 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3250 | Vaccines Administered (Flu) | active | | | 2009-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3273 | Vaccines Administered (Pediatric Flu) | active | | | 2009-01 | |
signal.core.r4 | R4 | ValueSet/questionnaire-ccars-current-living-arrangement | Questionnaire CCARS Current Living Arrangement | draft | 1 | pa | | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1010.7 | Clinical Drug Ingredient | active | | | 2024-06 | hl7 |
hl7.fhir.us.pacio-adi | R4 | ValueSet/ADIInitialTreatmentPMOOptionsVS | Initial Treatment Portable Medical Order Options | trial-use | 2 | pe | 2025-07 | hl7 |
fhir.virtually.healthcare | R4 | ValueSet/BARSReferralCode | BARS Referral Code | draft | | | 2025-07 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3130 | Injury Type (VPD) | active | | | 2008-01 | |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1032.308 | Cardiovascular disease 10Y risk | active | | | 2024-02 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1021.41 | MDP Test HL7 Intensional | active | | | 2019-01 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1032.266 | Rhabdomyolysis Intensional | active | | | 2024-06 | hl7 |
hl7.fhir.us.vrdr | R4 | ValueSet/vrdr-intentional-reject-vs | Intentional Reject ValueSet | active | | pher | 2024-10 | hl7 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-rhabdomyosarcoma-clinical-group-value-vs | Rhabdomyosarcoma Clinical Group Value | active | | cic | 2025-02 | hl7 |
hl7.fhir.us.breastcancer | R3 | ValueSet/shr-core-PositiveNegativeEquivocalIndeterminateVS | BC PositiveNegativeEquivocalIndeterminateVS ValueSet | draft | | | 2018-08 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7615 | Pre-Pregnancy SerologicalTestInterp (CRS) | active | | | 2017-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7476 | Positive Negative Equivocal Not Done | active | | | 2016-01 | |
hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-RecurrenceRiskScoreInterpretationVS | BC RecurrenceRiskScoreInterpretationVS ValueSet | draft | | | 2018-08 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7822 | Lab Test Type (Legionellosis) | active | | | 2018-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7336 | Lab Test Type (Mumps) | active | | | 2018-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7821 | Lab Test Type (Psittacosis) | active | | | 2018-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7844 | Lab Test Type (Lyme) | active | | | 2018-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7661 | Lab Test Type (Measles) | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7337 | Lab Test Type (Pertussis) | active | | | 2018-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3300 | Lab Test Procedure (Rubella) | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7549 | Test Type (Syphilis) | active | | | 2021-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3256 | Time Frame (Daily Weekly) | active | | | 2009-01 | |
hl7.fhir.us.registry-protocols | R4 | ValueSet/InterventionTypes | Intervention Types | active | | cic | 2023-11 | hl7 |
fhir.org.nz.ig.base | R4 | ValueSet/nz-residency | NZ Residency status | active | | | 2025-06 | hl7 |
hl7.fhir.us.codex-radiation-therapy | R4 | ValueSet/codexrt-radiotherapy-isotope-vs | Radiotherapy Isotope Value Set | active | | cgp | 2025-02 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1221.189 | Infertility, Male | active | | | 2024-04 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1221.190 | Infertility, Male | active | | | 2024-04 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1221.191 | Infertility, Male | active | | | 2024-04 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1222.1446 | Covid Toes (Toes and/or Fingers) | active | | | 2024-06 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1078.193 | relatedconditions_COPD I10 | active | | | 2023-03 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1078.173 | Asthma I10 | active | | | 2025-05 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1032.102 | Suicide Attempt | active | | | 2024-06 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1248.94 | Oxygen Partial Pressure in Arterial Blood | active | | | 2024-01 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1248.95 | Carbon Dioxide Partial Pressure in Arterial Blood | active | | | 2024-01 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1248.96 | Arterial Blood pH | active | | | 2024-01 | hl7 |
hl7.fhir.us.ccda | R4 | ValueSet/1.3.6.1.4.1.12009.10.2.5 | LOINC Imaging Document Codes | trial-use | | cgp | 2022-07 | hl7 |
hl7.fhir.us.ccda | R4 | ValueSet/2.16.840.1.113883.11.20.6.1 | ProcedureNoteDocumentTypeCodes | trial-use | | cgp | 2018-05 | hl7 |
hl7.fhir.us.ccda | R4 | ValueSet/2.16.840.1.113883.11.20.8.1 | ProgressNoteDocumentTypeCode | trial-use | | cgp | 2018-05 | hl7 |
hl7.fhir.us.pacio-adi | R4 | ValueSet/LOINCPOLSTCPRAnswerList | LOINC POLST CPR Answer List | trial-use | 2 | pe | 2025-07 | hl7 |
hl7.fhir.us.pacio-adi | R4 | ValueSet/LOINCPOLSTInitialTxAnswerList | LOINC POLST Initial Tx Answer List | trial-use | 2 | pe | 2025-07 | hl7 |
hl7.fhir.us.pacio-adi | R4 | ValueSet/LOINCPOLSTMedAssistNutrAnswerList | LOINC POLST Med assist nutr Answer List | trial-use | 2 | pe | 2025-07 | hl7 |
hl7.fhir.us.pacio-adi | R4 | ValueSet/LOINCPOLSTDiscussPartAnswerList | LOINC POLST discuss part List | trial-use | 2 | pe | 2025-07 | hl7 |
hl7.fhir.us.pacio-adi | R4 | ValueSet/LOINCPOLSTReviewAnswerList | LOINC POLST review Answer List | trial-use | 2 | pe | 2025-07 | hl7 |
hl7.fhir.us.registry-protocols | R4 | ValueSet/RoseDyspneaQ | Rose Dyspnea Questions | active | | cic | 2023-11 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1078.202 | Serum Creatinine | active | | | 2024-02 | hl7 |
hl7.fhir.us.registry-protocols | R4 | ValueSet/SeattleAnginaAs | Seattle Angina Answers | active | | cic | 2023-11 | hl7 |
hl7.fhir.us.davinci-pas | R4 | ValueSet/X12278DiagnosisInformationType | X12 278 Diagnosis Information Type | trial-use | 3 | fm | 2025-07 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.635 | LP(a) Test_ICD | active | | | 2025-03 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7755 | LTBI Drug Regimen (TB) | active | | | 2018-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7866 | Lab Test Method (MDRO) | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3358 | Lab Test Name (NND) | active | | | 2010-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7278 | Lab Test Performed Modifier (CS) | active | | | 2016-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3017 | Lab Test Result (PHLIP Flu) | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.6013 | Lab Test Type (Hepatitis) | active | | | 2022-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.6014 | Lab Test Type Enzymes (Hepatitis) | active | | | 2012-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3016 | Lab Test Order (PHLIP Flu) | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.4275 | Lab Result (Cancer Morphology) | active | | | 2011-01 | |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1260.50 | MSI High | active | | | 2023-11 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7892 | Lab Result (Candida auris) | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7895 | Lab Result Carbapenem Resistant Enterobacteriace | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.4024 | Lab Result (Cysticercosis) | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.4067 | Lab Result (Nontuberculous Mycobacteria) | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.4276 | Lab Result (Pesticide) | active | | | 2011-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7894 | Lab Test Name (Candida Auris) | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7893 | Lab Test Name Carbapenem Resistant Enterobacteria | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.8030 | Lab Test (Hansen) | active | | | 2021-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7733 | Lab Test Method (RIBD) | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1004 | Ordered Test | active | | | 2020-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7472 | Lab Test Type (Arbovirus) | active | | | 2018-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.8041 | Lab Test Type (Leptospirosis) | active | | | 2021-01 | |
hl7.fhir.us.core | R4 | ValueSet/us-core-laboratory-test-codes | US Core Laboratory Test Codes | trial-use | 3 | cgp | 2022-11 | hl7 |
fhir.cdc.opioid-cds-r4 | R4 | ValueSet/observation-category-laboratory | Observation Category Laboratory | active | | | 2023-05 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1002 | Lab Test Result Name | active | | | 2020-01 | |
hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-HER2byFISHVSInterpretationTestsVS | BC HER2byFISHVSInterpretationTestsVS ValueSet | draft | | | 2018-08 | hl7 |
hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-EstrogenReceptorInterpretationTestsVS | BC EstrogenReceptorInterpretationTestsVS ValueSet | draft | | | 2018-08 | hl7 |
hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-HER2byIHCInterpretationTestsVS | BC HER2byIHCInterpretationTestsVS ValueSet | draft | | | 2018-08 | hl7 |
hl7.fhir.us.breastcancer | R3 | ValueSet/oncology-ProgesteroneReceptorInterpretationTestsVS | BC ProgesteroneReceptorInterpretationTestsVS ValueSet | draft | | | 2018-08 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1003 | Observation Method | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.8037 | Test Type (Brucellosis) | active | | | 2021-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3097 | Present Absent Unknown Not Examined | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7612 | Late Clinical Manifestation (STD) | active | | | 2021-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.883 | PHIN Questions | active | | | 2013-01 | |
signal.core.r4 | R4 | ValueSet/questionnaire-ccars-legal-status | Questionnaire CCARS Legal Status | draft | 1 | pa | | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7714 | Legionella Diagnosis (RIBD) | active | | | 2018-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7715 | Legionella Exposure (RIBD) | active | | | 2018-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7737 | Legionellosis Serogroup (RIBD) | active | | | 2018-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7770 | Length of Time Drug Taken (TB) | active | | | 2018-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.7468 | Length of Gestation in Weeks | active | | | 2016-01 | |
hl7.fhir.us.registry-protocols | R4 | ValueSet/LesionSegmentNumber | Lesion Segment Number | active | | cic | 2023-11 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.921 | Emergency Department Acuity | active | | | 2008-01 | |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-clark-level-value-vs | Clark Level Value Set | active | | cic | 2025-02 | hl7 |
signal.core.r4 | R4 | ValueSet/questionnaire-answers-status | QuestionnaireResponseStatus | draft | 3 | fhir | 2019-10 | hl7 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-tnm-distant-metastases-staging-type-max-vs | TNM Distant Metastases Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | hl7 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-tnm-primary-tumor-staging-type-max-vs | TNM Primary Tumor Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | hl7 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-tnm-regional-nodes-staging-type-max-vs | TNM Regional Nodes Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | hl7 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-tnm-stage-group-staging-type-max-vs | TNM Stage Group Staging Type Maximum Value Set | active | 4 | cic | 2025-02 | hl7 |
hl7.fhir.us.mcode | R4 | ValueSet/mcode-condition-status-trend-max-vs | Condition Status Trend Maximum Value Set | active | 3 | cic | 2025-02 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.941 | Susceptibility Result | active | | | 2008-01 | |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.636 | Lp(a) Test_CPT | active | | | 2025-03 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.637 | LP(a) Test | active | | | 2025-03 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.634 | Lp(a) Test_LOINC | active | | | 2025-03 | hl7 |
us.nlm.vsac | R4 | ValueSet/2.16.840.1.113762.1.4.1235.633 | Lp(a) Test_SNOMED | active | | | 2025-03 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3241 | Notifiable Event Condition (Flu) | active | | | 2009-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3594 | Campylobacter Organism | active | | | 2010-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.988 | Countermeasure Encounter Purpose | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.989 | Countermeasure Encounter Type | active | | | 2008-01 | |
hl7.fhir.us.resp-net | R4 | ValueSet/resp-net-labtest-covid-codes | resp-net-labtest-covid-codes | draft | | | 2025-07 | hl7 |
hl7.fhir.us.resp-net | R4 | ValueSet/resp-net-labtest-flu-codes | resp-net-labtest-flu-codes | draft | | | 2025-07 | hl7 |
hl7.fhir.us.resp-net | R4 | ValueSet/resp-net-labtest-flu-rsv-covid-codes | resp-net-labtest-flu-rsv-covid-codes | draft | | | 2025-07 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.6047 | Message Structure (Syndromic Surveillance) | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.3244 | Medication Treatment (Flu) | active | | | 2009-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1073 | Microbiology Test Result Name | active | | | 2008-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.1107 | Notification Section Header | active | | | 2015-01 | |
hl7.fhir.us.resp-net | R4 | ValueSet/resp-net-labtest-rsv-codes | resp-net-labtest-rsv-codes | draft | | | 2025-07 | hl7 |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.6048 | Event Type (Syndromic Surveillance) | active | | | 2012-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.6049 | Message Type (Syndromic Surveillance) | active | | | 2019-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.6050 | Universal ID Type (Syndromic Surveillance) | active | | | 2012-01 | |
us.cdc.phinvads | R4 | ValueSet/2.16.840.1.114222.4.11.8012 | Activity Type (Brucellosis) | active | | | 2021-01 | |